ADO 0.00% 2.1¢ anteotech ltd

No not at all QUAGEN is mentioned in the first of the...

  1. 111 Posts.
    lightbulb Created with Sketch. 2

    No not at all

     QUAGEN is mentioned in the first of the announce




    Ellume’s partnerships with GSK and QIAGEN validates successful global Point of Care (POC) strategy•Ellume and Anteo collaboration confirms performance enhancing capabilities of AnteoBind for POC

     

    (from announcement)


    So obviously anteobind  will be used. .Why not expect some payment.

 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $54.77M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $37.13K 1.752M

Buyers (Bids)

No. Vol. Price($)
2 441468 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 668891 4
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.